Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fifteen ...

Is Arcellx, Inc. (ACLX) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

On Sunday, Arcellx, Inc. (NASDAQ:ACLX) revealed new data from its Phase 2 pivotal iMMagine-1 study of anitocabtagene autoleucel (anito-cel) in patients with relapsed or refractory multiple myeloma ...

H.C. Wainwright analyst Emily Bodnar has maintained their bullish stance on ACLX stock, giving a Buy rating today. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from ...

Below is Validea's guru fundamental report for ARCELLX INC (ACLX). Of the 22 guru strategies we follow, ACLX rates highest using our P/B Growth Investor model based on the published strategy of ...

Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

Arcellx's Cancer Cell Therapy Shows Deep, Durable Responses With Manageable Safety Profile In Heavily Pretreated Blood Cancer Patients Arcellx's Phase 2 trial of anito-cel in relapsed multiple ...

In a report released today, George Farmer from Scotiabank maintained a Buy rating on Arcellx Inc (ACLX – Research Report), with a price target of $82.00. The company’s shares closed yesterday ...